Xilio Therapeutics's market cap is currently $50.79M. The company's EPS TTM is $-1.719; its P/E ratio is ―; Xilio Therapeutics is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.90M	$ -1.85M	$ -1.50M	$ -1.06M	$ -240.00K
Operating Income	$ -79.13M	$ -89.15M	$ -75.04M	$ -54.56M	$ -19.03M
EBITDA	$ -73.80M	$ -85.58M	$ -73.70M	$ -53.50M	$ -17.07M
Net Income	$ -76.40M	$ -87.30M	$ -74.30M	$ -55.22M	$ -17.31M
Balance Sheet
Cash & Short-Term Investments	$ 44.70M	$ 120.39M	$ 198.05M	$ 19.24M	$ 48.84M
Total Assets	$ 60.93M	$ 139.16M	$ 218.06M	$ 36.32M	$ 62.72M
Total Debt	$ 11.46M	$ 19.94M	$ 20.54M	$ 21.22M	$ 18.63M
Net Debt	$ -33.25M	$ -100.45M	$ -177.52M	$ 1.98M	$ -30.21M
Total Liabilities	$ 24.10M	$ 33.52M	$ 32.63M	$ 119.60M	$ 92.25M
Stockholders' Equity	$ 36.83M	$ 105.65M	$ 185.43M	$ -83.29M	$ -29.52M
Cash Flow
Free Cash Flow	$ -69.11K	$ -77.59M	$ -81.85M	$ -38.28M	$ -18.56M
Operating Cash Flow	$ -68.62M	$ -75.72M	$ -80.75M	$ -36.09M	$ -17.84M
Investing Cash Flow	$ -486.00K	$ -1.87M	$ -1.10M	$ -2.19M	$ -715.00K
Financing Cash Flow	$ -6.55M	$ -69.00K	$ 260.67M	$ 10.03M	$ 60.02M

Currency in USD

Xilio Therapeutics Earnings and Revenue History

Income Statement >

Xilio Therapeutics Debt to Assets

Balance Sheet >

Xilio Therapeutics Cash Flow

Cash Flow >

Xilio Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing